Big Pharma Split Corp
Fund Quick Facts November 30, 2017
|TSX Code||PRM | PRM.PR.A|
|Total AUM||$31.9 million|
|Income Distribution PRM||Monthly|
|Income Distribution PRM.PR.A||Quarterly|
Top Ten Holdings
November 30, 2017
|Bristol-Myers Squibb Company||9.5|
|Merck & Co., Inc.||9.4|
|Johnson & Johnson||9.4|
|Eli Lilly and Company||9.4|
|GlaxoSmithKline PLC ADR||9.3|
|Novo Nordisk A/S||9.2|
|AstraZeneca PLC ADR||9.0|
The Company will invest in an initially equally-weighted portfolio comprised of Equity Securities of ten issuers, selected by the Portfolio Manager from the Investable Universe, that at the time of investment and immediately following each semi-annual reconstitution and rebalancing: (i) are listed on a North American exchange; (ii) pay a dividend; and (iii) have options in respect of its Equity Securities that, in the opinion of the Portfolio Manager, are sufficiently liquid to permit the Portfolio Manager to write options in respect of such securities. The Portfolio will be comprised primarily of the largest (as determined by market capitalization calculated in US$) Pharmaceutical Issuers in the Investable Universe.
The Manager will hedge substantially all of the Portfolio’s U.S dollar exposure back to the Canadian dollar.
The Class A Shares provide holders a monthly cash distribution and are targeted to be $0.1031 per share and, for the Preferred Shares, quarterly cash distributions are fixed at $0.1250 per share.
Cumulative Growth $10,000 Invested
|Harvest Portfolios Group Inc.
PAUL MACDONALD, CFA
Chief Investment Officer
JAMES LEARMONTH, CFA
Investors seeking income through investment in the world's leading pharmaceutical companies.
Investors seeking to hold their investment for medium to long term.
Big Pharma Split Corp
Quarterly Portfolio Holdings
as of :
|Security||% of Portfolio|
|November 24, 2017||Big Pharma Split Corp. closes $34 million Initial Public Offering|
|October 30, 2017||Big Pharma Split Corp. Files Final Prospectus|
|September 26, 2017||Big Pharma Split Corp. Announces Filing of Preliminary Prospectus|
November 24, 2017 to June 30, 2018
You will usually pay brokerage fees to your dealer if you purchase or sell units of the Fund on the TSX. If units are purchased or sold on the TSX, investors may pay more than the current net asset value when buying units of the Fund and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning units of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash from the Class A or Preferred Class of the Fund. If the Fund earns less than the amount distributed, the difference is a return of capital. The current yield is calculated based on the market price of the Fund. The information contained herein is not an offer to sell nor a solicitation to buy any security. Such an offer can only be made by prospectus or other applicable offering document.